AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Short Implant Versus Crestal Standard Length Implant to Retain Class 1 Removable Partial Denture.

RecruitingNAAges 50 Years - 70 YearsAllMenoufia University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Objective: To report the implant survival rates, clinical, and radiographic outcomes of subcrestal short implant versus crestal standard length implant supported removable partial denture (RPD).

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria * adult patients aged 50 years or older with class 1 RPD with missing mandibular molars at least and complaining from instability of the prosthesis were recruited. * Medical history revealed no contraindication to implant therapy. * Patients have an amount of bone nearly equal to 8 mm length above the inferior alveolar canal to receive a 6 mm short implant with 2 mm subcrestal to the bone level with sufficient bone width โ‰ฅ 8mm on one side and an amount of bone equal to or more than 8 mm to receive a standard-length implant of 7.5, 9, or 10.5 mm placed at crestal bone level with sufficient bone width โ‰ฅ 8mm on the contralateral side which was examined by CBCT. Exclusion Criteria: * Presence of active infection or inflammation in the areas intended for implant placement; \*systemic diseases such as diabetes. * Pregnant and lactating patients. * Habit of severe bruxism or clenching. * Treatment with therapeutic radiation to the head within the past 12 months. * Treatment with bisphosphonate within the past 12 months. * More than 10 cigarettes/day smoking habit.
๐Ÿ’Š

What it tests

  • Titanium dental implant (Conical SPI, Vitronix, Italy), Medical device that interfaces with the jawbone to support a dental prosthesis.
๐Ÿ“

Where

1 site
Mohammed A. El-Sawy
Al Mansurah, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy